|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.300 CNY | +1.47% |
|
+14.80% | +4.53% |
| Market Cap | 4.83B 711M 622M 571M 533M 1.01B 67.72B 1.03B 6.86B 2.67B 33.29B 2.67B 2.61B 115B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.66B 686M 600M 551M 514M 975M 65.36B 990M 6.62B 2.57B 32.13B 2.58B 2.52B 111B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | +1.47% | ||
| 1 week | +14.80% | ||
| Current month | +8.21% | ||
| 1 month | +4.80% | ||
| 3 months | -17.17% | ||
| 6 months | +4.53% | ||
| Current year | +4.53% |
| 1 week | 7.08 |  | 8.56 |
| 1 month | 7.08 | | 8.56 |
| Current year | 7.08 | | 11.38 |
| 1 year | 7.08 | | 11.98 |
| 3 years | 3.58 | | 11.98 |
| 5 years | 3.58 | | 11.98 |
| 10 years | 3.58 | | 15.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 10/12/2017 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 31/07/2019 |
Sen Li
COO | Chief Operating Officer | 45 | 24/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 31/07/2019 |
Ying Yang
CHM | Chairman | 48 | 20/03/2019 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 20/03/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.47% | +14.80% | -17.08% | +24.44% | 711M | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +31.35% | +24.29% | 338B | |
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | |
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | |
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +2.03% | +4.69% | +26.19% | +54.48% | 369.31B | |
| Weighted average by Cap. | +2.24% | +5.53% | +41.77% | +82.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 145M 127M 116M 109M 206M 13.8B 209M 1.4B 543M 6.78B 544M 532M 23.37B | 1.21B 178M 155M 143M 133M 252M 16.91B 256M 1.71B 666M 8.31B 667M 652M 28.64B |
| Net income | 13.65M 2.01M 1.76M 1.62M 1.51M 2.86M 191M 2.9M 19.4M 7.54M 94.13M 7.55M 7.39M 324M | 92.73M 13.66M 11.94M 10.98M 10.23M 19.41M 1.3B 19.7M 132M 51.22M 639M 51.28M 50.18M 2.2B |
| Net Debt | 189M 27.86M 24.35M 22.38M 20.86M 39.57M 2.65B 40.17M 269M 104M 1.3B 105M 102M 4.49B | -169M -24.87M -21.74M -19.98M -18.62M -35.32M -2.37B -35.86M -240M -93.25M -1.16B -93.35M -91.35M -4.01B |
Employees
1,188
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | CN¥8.300 | +1.47% | 21,781,818 |
| 02/07/26 | CN¥8.180 | -0.73% | 30,346,238 |
| 01/07/26 | CN¥8.240 | +7.43% | 38,713,870 |
| 30/06/26 | CN¥7.670 | -2.29% | 23,485,763 |
| 29/06/26 | CN¥7.850 | +8.58% | 31,887,683 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
